Demant
Health Care Equipment
Denmark
ESRS disclosure: S4-4_12
Tags Tree
Selected: 0
No matching results found.
- What resources are allocated by your organization to manage its material impacts on consumers and end-users, including the approaches taken to address material risks and pursue material opportunities, and how effective are these actions?
-
Question Id: S4-4_12
Demant is committed to continuous R&D investment to drive innovation and ensure technological leadership. In 2024, Demant invested DKK 1,394 million in R&D. The company engages with users and consumers to provide life-changing hearing health, focusing on innovation and service in hearing care clinics. They have established user communication procedures and engage in global efforts to put hearing health on the map through initiatives like the International Campaign for Better Hearing.
Report Date: 4Q2024Relevance: 65%